Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...
Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...
By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...
Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...
Last month, the FDA declined to approve Sanofi’s tolebrutinib for a specific form of multiple sclerosis. In a recently ...
For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis ...
MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), which includes the brain, spinal cord, and optic nerves. In MS, your immune system attacks myelin ...
She had survived the trials and tribulations of cancer and was feeling positive about the future. But then Sally Burton, 61, ...
As though battling cancer wasn't enough of a struggle, Sally was simultaneously dealing with a spinal bulge diagnosis that ...
Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for demyelinating diseases, today announced that it closed its Series A Extension Round of CAD$10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback